Email:
[email protected]
Login
Register
English
Deutsch
Español
Français
Português
Home
Add new document
Sign In
Create An Account
PMH15 Development of A Self-Administered Outcome Measure for Use in An Outpatient Population of Individuals with Schizophrenia
HOME
PMH15 Development of A Self-Administered Outcome Measure for Use in An Outpatient Population of Individuals with Schizophrenia
PMH15 Development of A Self-Administered Outcome Measure for Use in An Outpatient Population of Individuals with Schizophrenia
PMH15 Development of A Self-Administered Outcome Measure for Use in An Outpatient Population of Individuals with Schizophrenia - PDF Download Free
Download PDF
1022KB Sizes
0 Downloads
4 Views
Report
Recommend Documents
The Development of an Outcome Measure for Consultation Liaison Psychiatry
Development of a measure of relationship perception in schizophrenia
Development and validation of a rhinoconjunctivitis and asthma symptom score for use as an outcome measure in clinical trials
The Schizophrenia Caregiver Quality of Life questionnaire (S-CGQoL): Development and validation of an instrument to measure quality of life of caregivers of individuals with schizophrenia
The Schizophrenia Caregiver Quality of Life questionnaire (S-CGQoL): Development and validation of an instrument to measure quality of life of caregivers of individuals with schizophrenia
Use of antipsychotic medications among HIV-infected individuals with schizophrenia
Development and validation of the Composite Asthma Severity Index—an outcome measure for use in children and adolescents
Development and validation of the Composite Asthma Severity Index—an outcome measure for use in children and adolescents
Metabolic health in patients with schizophrenia – CVD risk in a Norwegian outpatient population
274 Development and Testing of a Patient-Reported Outcome Measure for Use With Emergency Department Patients Who Are Discharged Home
Physical activity pattern and cardiorespiratory fitness in individuals with schizophrenia compared with a population-based sample
PMH15: A RETROSPECTIVE ECONOMIC EVALUATION OF OLANZAPINE VERSUS RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA
PDF Reader
Full Text
PMH15 Development of A Self-Administered Outcome Measure for Use in An Outpatient Population of Individuals with Schizophrenia - Full Text by Download PDF Free
×
Report "PMH15 Development of A Self-Administered Outcome Measure for Use in An Outpatient Population of Individuals with Schizophrenia"
Your name
Email
Reason
-Select Reason-
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Description
Our partners will collect data and use cookies for ad personalization and measurement.
Learn how we and our ad partner Google, collect and use data
.
Agree & close